The umbilical cords utilized by our affiliated cell expansion partners are certified ethically sourced umbilical cords obtained from consenting adult birth mothers who are between the ages of 18 and 25 and who have been monitored closely during their pregnancy and have undergone extensive testing. Both birth parents of the umbilical cord donor have had their medical history properly evaluated, verified, and vetted to ensure no medical history of cancer, Alzheimer’s, other neurological diseases, autism spectrum disorder nor any associated risk factors. All children from whom the umbilical cord was obtained were successfully delivered during full-term cesarian section birth in a certified hospital. The Wharton’s Jelly-derived umbilical cord-derived Mesenchymal stem cells utilized by Trinity Stem Cells are capable of differentiating into bone cells, fatty cells, cartilage, neurones, muscle, etc.
Mesenchymal stem cells (MSCs) are advantageous over other stem cells types for a variety of reasons. First, they avoid the ethical issues that surround embryonic stem cell research.
Second, Repeated studies have found MSCs to be immune-privileged, which makes them an advantageous cell type for allogeneic transplantation. MSCs reduce both the risks of rejection and complications of transplantation.
Third, there have been advances in the use of umbilical cord mesenchymal stem cells to regenerate human tissues, including cartilage, meniscus, tendons, and bone fractures, because MSCs can exert regenerative effects through homing to sites of damage, paracrine signalling, regulating immune responses, and positively affecting the microenvironment.